Longitudinal SARS-CoV-2 seroprevalence in Portugal and antibody maintenance 12 months after the start of the COVID-19 pandemic. Preprint
GHDx Entry last modified on: Sep 13, 2022
Incidence
Dataset Records for Incidence
Displaying 1 - 50 of 7946
Brazil - Sergipe Evolution of the Prevalence of SARS-CoV-2 Infection 2021, Third Phase
Evolução da Prevalência de Infecção por SARS-CoV-2 em Sergipe. Terceira Fase: 18 de fevereiro a 30 de março de 2021.
Survey:
Epi surveillance
Portugal National Serological Survey COVID-19 (2nd phase) 2021
Inquérito Serológico Nacional COVID-19 (2.ª fase) (INS COVID-19)
Survey:
Individual
Zimbabwe COVID-19 Daily Update 2021
GHDx Entry last modified on: Dec 22, 2022
Brazil - São Paulo Household Survey to Estimate the Seroprevalence of SARS-CoV-2 Infection, Phase 5 (SoroEpi MSP)
Avaliação da prevalência da infecção pelo vírus SARS-CoV-2 em habitantes do município de São Paulo: Resultados Parciais da Fase 5
Bhutan Royal Centre for Disease Control Quarterly Bulletin: First Quarter, Volume 25, January-March 2021
RCDC 1st Quarterly Bulletin Volume 25, Jan -March 2021
Epi surveillance:
Subnationally representative
Serological prevalence of SARS-CoV-2 antibody among children and young age (between age 2-17 years) group in India: An interim result from a large multi-centric population-based seroepidemiological study. Preprint
GHDx Entry last modified on: Apr 8, 2022
Genomic Overview of SARS-CoV-2 in Denmark, Lineages and Mutations of Interest: B.1.1.7
GHDx Entry last modified on: Sep 9, 2022
Anti-spike protein receptor-binding domain IgG levels after COVID-19 infection or vaccination against SARS-CoV-2 in a seroprevalence study. Preprint
GHDx Entry last modified on: May 12, 2022
Genomic Overview of SARS-CoV-2 in Denmark, Lineages and Mutations of Interest: B.1.351
GHDx Entry last modified on: Sep 9, 2022
Seroprevalence of SARS-CoV-2 infection in the Colombo Municipality region, Sri Lanka. Preprint
GHDx Entry last modified on: Mar 14, 2022
Genomic Overview of SARS-CoV-2 in Denmark, Lineages and Mutations of Interest: B.1.525
GHDx Entry last modified on: Sep 9, 2022
SARS-CoV-2 antibody prevalence in Sierra Leone, March 2021: a cross-sectional, nationally representative, age-stratified serosurvey. Preprint
GHDx Entry last modified on: Mar 14, 2022
Genomic Overview of SARS-CoV-2 in Denmark, Lineages and Mutations of Interest: P.1
GHDx Entry last modified on: Sep 9, 2022
Socioeconomic position and SARS-CoV-2 infections: seroepidemiological findings from a German nationwide dynamic cohort. Preprint
GHDx Entry last modified on: Mar 14, 2022
Covid-19 Vaccination Strategy In Spain 2020-2022
Estrategia De Vacunación Covid-19 En Espana
Serum-epidemiological Survey of SARS-CoV-2, Cities of Xai-Xai and Chókwè (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Xai-Xai e Chókwè (InCOVID 2020) - Resultados Preliminares -
Canada - British Columbia COVID-19 Situation Report 2020-2022
British Columbia (BC) COVID-19 Situation Report
South Africa COVID-19 Special Public Health Surveillance Bulletin, Volume 18 Supplementary Issue 9, 12 March 2021
COVID-19 Special Public Health Surveillance Bulletin Volume 18 (Issue 9: 12 Mar 2021)
Epi surveillance:
Cross-sectional - Individual
Brazil - Sao Paulo Household Survey to Estimate the Seroprevalence of SARS-CoV-2 Infection, Phase 4 (SoroEpi MSP)
Avaliação da prevalência da infecção pelo vírus SARS-CoV-2 em habitantes do município de São Paulo: Resultados Parciais da Fase 4
Bhutan Royal Centre for Disease Control Quarterly Disease Surveillance Bulletin: Fourth Quarter, October-December 2020
RCDC Surveillance Bullletin, Volume 24, 4th Quarter 2020 (1st Quarter to 30 December) 2020
Epi surveillance:
Subnationally representative
4.7% of the Austrian population had antibodies against SARS-CoV -2 in mid / late October
GHDx Entry last modified on: May 12, 2022
Population-based seroprevalence of SARS-CoV-2 antibodies in a high-altitude setting in Peru. Preprint
GHDx Entry last modified on: May 12, 2022
Serum-epidemiological Survey of SARS-CoV-2, City of Lichinga (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Lichinga (InCOVID 2020) - Resultados Preliminares -
Serum-epidemiological Survey of SARS-CoV-2, City of Beira (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Beira (InCOVID 2020) - Resultados Preliminares -
Serum-epidemiological Survey of SARS-CoV-2, City of Tete (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Tete (InCOVID 2020) - Resultados Preliminares -
India - Jharkhand Regional Outreach Bureau Twitter Communications and COVID-19 Updates
GHDx Entry last modified on: Oct 14, 2022
Serum-epidemiological Survey of SARS-CoV-2, City of Maputo (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Maputo (InCOVID 2020) - Resultados Preliminares -
About 10 million people have been infected with the Corona virus in Afghanistan
حدود ده ملیون تن در افغانستان به ویروس کرونا مبتلا شده اند
Serum-epidemiological Survey of SARS-CoV-2, City of Quelimane (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Quelimane (InCOVID 2020) - Resultados Preliminares -
Prevalence and Time Trend of SARS-CoV-2 Infection in Puducherry, India, August-October 2020
GHDx Entry last modified on: Jun 17, 2021
United States - Washington Hospitalized or Ambulatory Adults with Respiratory Viral Infections 2020
HAARVI
Survey:
Health facility - Longitudinal - Outpatient
Mexico National Health and Nutrition Survey (ENSANUT) about COVID-19 2020
Encuesta Nacional de Salud y Nutrición 2020 sobre Covid-19, ENSANUT Continua COVID-19
Epi surveillance:
Household - Interview - Urban-rural representative
Prevalence of SARS-CoV-2 in six districts in Zambia in July, 2020: a cross-sectional cluster sample survey
GHDx Entry last modified on: Feb 10, 2022
Serum-epidemiological Survey of SARS-CoV-2, City of Pemba (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Pemba (InCOVID 2020) - Resultados Preliminares -
Bhutan Royal Centre for Disease Control Quarterly Disease Surveillance Bulletin: Third Quarter, July-September 2020
RCDC Surveillance Bullletin, 28-39 Weeks, Volume 23, 3rd Quarter 2020 (1st July to 30 September) 2020
Epi surveillance:
Subnationally representative
CDC COVID Data Tracker Nationwide Blood Donor Seroprevalence Survey 2021-2022
Survey:
Epi surveillance - Subnationally representative
Laboratory Confirmed Cases of Pertussis in England: July to September 2020
Health Protection Report Volume 15 Number 3
Australia Notifications of COVID-19 by Age Group and Sex
Number of notifications of COVID-19*, Australia, by age group and sex
Seroprevalence of anti-SARS-CoV-2 antibodies in Iquitos, Loreto, Peru. Preprint
GHDx Entry last modified on: Jun 18, 2021
Afghanistan National COVID-19 Prevalence and Related Deaths Survey 2020
National Survey of Prevalence of COVID-19 and its Related Deaths in Afghanistan
Survey:
Cross-sectional - Individual - Interview - Nationally representative - Subnationally representative - Urban-rural representative
Montenegro Institute of Public Health COVID-19 Dashboard June 2020
GHDx Entry last modified on: May 12, 2022
United States - Rhode Island Department of Health COVID-19 Data Tracker 2020
GHDx Entry last modified on: Oct 14, 2022
Seroprevalence of SARS-CoV-2 IgM and IgG antibodies in an asymptomatic population in Sergipe, Brazil
GHDx Entry last modified on: Jun 17, 2021
Popova declared immunity to coronavirus in 14% of those tested
Попова заявила об иммунитете к коронавирусу у 14% протестированных
The seroprevalence of SARS-CoV-2 IgG antibodies among asymptomatic blood donors in Saudi Arabia
GHDx Entry last modified on: Jun 17, 2021
Fernando de Noronha: how an island controlled the community transmission of COVID-19 in Brazil. Preprint
GHDx Entry last modified on: Mar 14, 2022
Subscribe